{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:02:34Z","timestamp":1790337754428,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jval.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:23:33Z","timestamp":1788017013000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review"],"prefix":"10.1016","author":[{"given":"Sarayuth","family":"Khuntha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitaporn","family":"Youngkong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukrit","family":"Sitthiboot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montarat","family":"Thavorncharoensap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2026.08.003_bib1","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional cost-effectiveness analysis: a tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med Decis Mak"},{"issue":"9","key":"10.1016\/j.jval.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40273-016-0414-z","article-title":"Extended cost-effectiveness analysis for health policy assessment: a tutorial","volume":"34","author":"Verguet","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2026.08.003_bib4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"42","key":"10.1016\/j.jval.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1016\/j.vaccine.2013.07.014","article-title":"Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis","volume":"31","author":"Verguet","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12913-022-07595-1","article-title":"Meta-analysis of economic evaluation studies: data harmonisation and methodological issues","volume":"22","author":"Bagepally","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/14737167.2015.1103185","article-title":"Risk of bias in model-based economic evaluations: the ECOBIAS checklist","volume":"16","author":"Adarkwah","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12936-020-3103-5","article-title":"Health gains and financial risk protection afforded by public financing of selected malaria interventions in Ethiopia: an extended cost-effectiveness analysis","volume":"19","author":"Assebe","year":"2020","journal-title":"Malar J"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12936-022-04113-w","article-title":"Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis","volume":"21","author":"Dasgupta","year":"2022","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/heapol\/czz181","article-title":"Who benefits most from extending financial protection for cataract surgery in Vietnam? An extended cost-effectiveness analysis of small incision surgery","volume":"35","author":"Essue","year":"2020","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007824","article-title":"Equity impact of minimum unit pricing of alcohol on household health and finances among rich and poor drinkers in South Africa","volume":"7","author":"Gibbs","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"11","key":"10.1016\/j.jval.2026.08.003_bib13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/tmi.12766","article-title":"Rotavirus vaccines contribute towards universal health coverage in a mixed public\u2014private healthcare system","volume":"21","author":"Loganathan","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/23288604.2017.1413494","article-title":"The health gains, financial risk protection benefits, and distributional impact of increased tobacco taxes in Armenia","volume":"4","author":"Postolovska","year":"2018","journal-title":"Health Syst Reform"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12939-021-01603-2","article-title":"The distributional effects of tobacco tax increases across regions in Mexico: an extended cost-effectiveness analysis","volume":"21","author":"Saenz-de-Miera","year":"2022","journal-title":"Int J Equity Health"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2471\/BLT.18.219980","article-title":"Modelling the impact of a tax on sweetened beverages in the Philippines: an extended cost-effectiveness analysis","volume":"97","author":"Saxena","year":"2019","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001317","article-title":"The distributional impact of taxing sugar-sweetened beverages: findings from an extended cost-effectiveness analysis in South Africa","volume":"4","author":"Saxena","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"12","key":"10.1016\/j.jval.2026.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168867","article-title":"Sustainable development in surgery: the health, poverty, and equity impacts of charitable surgery in Uganda","volume":"11","author":"Shrime","year":"2016","journal-title":"PLOS One"},{"issue":"9","key":"10.1016\/j.jval.2026.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011586","article-title":"Maternal-related deaths and impoverishment among adolescent girls in India and Niger: findings from a modelling study","volume":"6","author":"Verguet","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.07.020701","article-title":"Distributional benefits of tobacco tax and smoke-free workplaces in China: a modeling study","volume":"7","author":"Verguet","year":"2017","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/heapol\/czv023","article-title":"Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis","volume":"31","author":"Watkins","year":"2016","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13561-021-00328-w","article-title":"Distributional health and financial consequences of increased cigarette tax in Iran: extended cost-effectiveness analysis","volume":"11","author":"Raei","year":"2021","journal-title":"Health Econ Rev"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000613","article-title":"Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study","volume":"3","author":"Riumallo-Herl","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/injuryprev-2015-041650","article-title":"Helmet regulation in Vietnam: impact on health, equity and medical impoverishment","volume":"22","author":"Olson","year":"2016","journal-title":"Inj Prev"},{"issue":"6","key":"10.1016\/j.jval.2026.08.003_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/heapol\/czab052","article-title":"Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study","volume":"36","author":"Portnoy","year":"2021","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.jval.2026.08.003_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.socscimed.2016.10.020","article-title":"The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon","volume":"170","author":"Salti","year":"2016","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.jval.2026.08.003_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/heapol\/czv121","article-title":"Task-sharing or public finance for the expansion of surgical access in rural Ethiopia: an extended cost-effectiveness analysis","volume":"31","author":"Shrime","year":"2016","journal-title":"Health Policy Plan"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016402","article-title":"Modelling the health, financial protection and equity impacts of upscaling the ACT NOW early intervention breast cancer pilot program in the Philippines: an extended cost-effectiveness analysis","volume":"10","author":"Chye","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40795-024-00941-y","article-title":"Modelling the potential impact of a tax on fruit juice in South Africa: implications for the primary prevention of type 2 diabetes and health financing","volume":"10","author":"Boachie","year":"2024","journal-title":"BMC Nutr"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.17711\/SM.0185-3325.2020.010","article-title":"Cost-effectiveness analysis of interventions to achieve universal health coverage for schizophrenia in Mexico","volume":"43","author":"Cabello-Rangel","year":"2020","journal-title":"Salud Ment"},{"issue":"3","key":"10.1016\/j.jval.2026.08.003_bib31","first-page":"376","article-title":"Health gains and financial protection provided by the Ethiopian mental health strategy: an extended cost-effectiveness analysis","volume":"32","author":"Johansson","year":"2017","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.jval.2026.08.003_bib32","series-title":"Injury Prevention and Environmental Health","first-page":"223","article-title":"Household energy interventions and health and finances in Haryana, India: an extended cost-effectiveness analysis","author":"Pillarisetti","year":"2017"},{"issue":"3","key":"10.1016\/j.jval.2026.08.003_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/epi.13294","article-title":"Health and economic benefits of public financing of epilepsy treatment in India: an agent-based simulation model","volume":"57","author":"Megiddo","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.jval.2026.08.003_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.socscimed.2015.06.018","article-title":"Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: an extended cost-effectiveness analysis","volume":"139","author":"Driessen","year":"2015","journal-title":"Soc Sci Med"},{"issue":"24","key":"10.1016\/j.jval.2026.08.003_bib35","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.vaccine.2015.02.052","article-title":"An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China","volume":"33","author":"Levin","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib36","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S2214-109X(15)70095-1","article-title":"The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis","volume":"3","author":"Verguet","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.jval.2026.08.003_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hec.3019","article-title":"Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis","volume":"24","author":"Verguet","year":"2015","journal-title":"Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2026.08.003_bib38","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2214-109X(22)00552-6","article-title":"Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis","volume":"11","author":"Dixit","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib39","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/S2214-109X(23)00056-6","article-title":"Effects of public financing of essential maternal and child health interventions across wealth quintiles in Nigeria: an extended cost-effectiveness analysis","volume":"11","author":"Mao","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jval.2026.08.003_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114076","article-title":"Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia","volume":"281","author":"Enden","year":"2021","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.jval.2026.08.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002326","article-title":"Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: a cost-effectiveness and equity analysis","volume":"14","author":"Lal","year":"2017","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.jval.2026.08.003_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006402","article-title":"Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia","volume":"5","author":"Pecenka","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2026.08.003_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.12688\/gatesopenres.13127.1","article-title":"Impact of cigarette tax increase on health and financing outcomes in four Indian states","volume":"4","author":"Wu","year":"2020","journal-title":"Gates Open Res"},{"key":"10.1016\/j.jval.2026.08.003_bib44","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.12688\/gatesopenres.13051.1","article-title":"Impact of cigarette price increase on health and financing outcomes in Vietnam","volume":"3","author":"Wu","year":"2019","journal-title":"Gates Open Res"},{"key":"10.1016\/j.jval.2026.08.003_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12962-016-0058-z","article-title":"An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance","volume":"14","author":"Raykar","year":"2016","journal-title":"Cost Eff Resour Alloc"},{"issue":"12","key":"10.1016\/j.jval.2026.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142691","article-title":"Health gains and financial protection from pneumococcal vaccination and pneumonia treatment in Ethiopia: results from an extended cost-effectiveness analysis","volume":"10","author":"Johansson","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0266462312000050","article-title":"Can cost-effectiveness analysis integrate concerns for equity? Systematic review","volume":"28","author":"Johri","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2026.08.003_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.socscimed.2017.12.012","article-title":"Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review","volume":"198","author":"Dukhanin","year":"2018","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.jval.2026.08.003_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/1753-6405.12709","article-title":"Inclusion of equity in economic analyses of public health policies: systematic review and future directions","volume":"42","author":"Lal","year":"2018","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jval.2020.10.010","article-title":"Examining equity effects of health interventions in cost-effectiveness analysis: a systematic review","volume":"24","author":"Avance\u00f1a","year":"2021","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40273-021-01094-7","article-title":"Incorporating equity concerns in cost-effectiveness analyses: a systematic literature review","volume":"40","author":"Ward","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14737167.2021.1954505","article-title":"Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review","volume":"22","author":"Yang","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.jval.2026.08.003_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/ijerph20010505","article-title":"Challenges and limitations in distributional cost-effectiveness analysis: a systematic literature review","volume":"20","author":"Steijger","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.jval.2026.08.003_bib56","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/vaccines11030622","article-title":"Equity-informative economic evaluations of vaccines: a systematic literature review","volume":"11","author":"Patikorn","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jval.2026.08.003_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12962-018-0102-2","article-title":"Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries","volume":"16","author":"Boujaoude","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"issue":"3-04","key":"10.1016\/j.jval.2026.08.003_bib58","first-page":"205","article-title":"Health economics and equity in preconception health care: a systematic review","volume":"40","author":"Carrandi","year":"2022","journal-title":"Semin Reprod Med"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526026033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526026033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:22:09Z","timestamp":1790335329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526026033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S1098301526026033"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.08.003","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}